Beyond Biotech Podcast: Mainz Biomed

Show Notes 2:18 news 3: 46 Mainz Biomed This week, we have a conversation with Mainz Biomed CEO, Guido Bächler. Mainz Biomed Provides Year-End 2022 Corporate Review Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced its corporate summary for the fiscal year ended December 31, 2022. […]